APA (7th ed.) Citation

Higgins, G., Roper, K. M., Watson, I. J., Blackhall, F. H., Rom, W. N., Pass, H. I., . . . Coverley, D. (2012). Variant Ciz1 is a circulating biomarker for early-stage lung cancer. Proceedings of the National Academy of Sciences - PNAS, 109(45), E3128-E3135. https://doi.org/10.1073/pnas.1210107109

Chicago Style (17th ed.) Citation

Higgins, Gillian, Katherine M. Roper, Irene J. Watson, Fiona H. Blackhall, William N. Rom, Harvey I. Pass, Justin F. X. Ainscough, and Dawn Coverley. "Variant Ciz1 Is a Circulating Biomarker for Early-stage Lung Cancer." Proceedings of the National Academy of Sciences - PNAS 109, no. 45 (2012): E3128-E3135. https://doi.org/10.1073/pnas.1210107109.

MLA (9th ed.) Citation

Higgins, Gillian, et al. "Variant Ciz1 Is a Circulating Biomarker for Early-stage Lung Cancer." Proceedings of the National Academy of Sciences - PNAS, vol. 109, no. 45, 2012, pp. E3128-E3135, https://doi.org/10.1073/pnas.1210107109.